Par Pharmaceutical, headquartered in Chestnut Ridge, NY, develops, manufactures and markets safe, innovative and cost-effective generic pharmaceutical and branded injectable products that help improve patient quality of life. Par, among the top leaders in the U.S. generics industry, possesses a portfolio that includes sterile injectables, alternative dosage forms and many other differentiated products. Par is advancing a robust research and development (R&D) pipeline of potential products. Par is an operating company of Endo International plc (NASDAQ: ENDP), a highly focused generics and specialty branded pharmaceutical company delivering quality medicines to patients through excellence in development, manufacturing and commercialization. Learn more at www.endo.com or www.parpharm.com
quality you can depend on
High-quality and cost-effective products with the highest level of customer service.
facilities & manufacturing
Learn more about our state of the art facilities, distribution center, and our manufacturing & packaging capabilities.
our generics products
We offer an extensive range of prescription and over-the-counter products across a wide range of therapeutic areas.